Canby-Hagino ED - Search Results

1

Intraluminal pneumatic lithotripsy for the removal of encrusted urinary catheters.

Canby-Hagino ED, Caballero RD, Harmon WJ. Canby-Hagino ED, et al. J Urol. 1999 Dec;162(6):2058-60. doi: 10.1016/S0022-5347(05)68100-1. J Urol. 1999. PMID: 10569569

2

Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk.

Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Griffith BC, et al. J Urol. 2002 Sep;168(3):1021-3. doi: 10.1016/S0022-5347(05)64565-X. J Urol. 2002. PMID: 12187213 Clinical Trial.

3

Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy.

Canby-Hagino ED, Morey AF, Jatoi I, Perahia B, Bishoff JT. Canby-Hagino ED, et al. J Urol. 2000 Dec;164(6):2004-5. J Urol. 2000. PMID: 11061902

4

Prostate cancer risk with positive family history, normal prostate examination findings, and PSA less than 4.0 ng/mL.

Canby-Hagino E, Hernandez J, Brand TC, Troyer DA, Higgins B, Ankerst DP, Thompson IM, Leach RJ, Parekh DJ. Canby-Hagino E, et al. Urology. 2007 Oct;70(4):748-52. doi: 10.1016/j.urology.2007.06.1105. Urology. 2007. PMID: 17991549

5

Association of polymorphisms in TGFB1 and prostate cancer prognosis.

Brand TC, Bermejo C, Canby-Hagino E, Troyer DA, Baillargeon J, Thompson IM, Leach RJ, Naylor SL. Brand TC, et al. J Urol. 2008 Feb;179(2):754-8. doi: 10.1016/j.juro.2007.09.020. Epub 2007 Dec 20. J Urol. 2008. PMID: 18082198

6

Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.

Thompson IM, Tangen CM, Paradelo J, Lucia MS, Miller G, Troyer D, Messing E, Forman J, Chin J, Swanson G, Canby-Hagino E, Crawford ED. Thompson IM, et al. J Urol. 2009 Mar;181(3):956-62. doi: 10.1016/j.juro.2008.11.032. Epub 2009 Jan 23. J Urol. 2009. PMID: 19167731 Free PMC article. Clinical Trial.

7

External validation of the Prostate Cancer Prevention Trial risk calculator in a screened population.

Parekh DJ, Ankerst DP, Higgins BA, Hernandez J, Canby-Hagino E, Brand T, Troyer DA, Leach RJ, Thompson IM. Parekh DJ, et al. Urology. 2006 Dec;68(6):1152-5. doi: 10.1016/j.urology.2006.10.022. Urology. 2006. PMID: 17169636

8

Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis.

Beuten J, Garcia D, Brand TC, He X, Balic I, Canby-Hagino E, Troyer DA, Baillargeon J, Hernandez J, Thompson IM, Leach RJ, Naylor SL. Beuten J, et al. J Urol. 2009 Oct;182(4):1614-20. doi: 10.1016/j.juro.2009.06.016. Epub 2009 Aug 15. J Urol. 2009. PMID: 19683737

9

Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention.

Canby-Hagino E, Hernandez J, Brand TC, Thompson I. Canby-Hagino E, et al. Eur Urol. 2007 Jan;51(1):27-33. doi: 10.1016/j.eururo.2006.09.002. Epub 2006 Sep 15. Eur Urol. 2007. PMID: 17030406 Review.

10

Prognostic features in men who died of prostate cancer.

Thompson KE, Hernández J, Canby-Hagino ED, Troyer D, Thompson IM. Thompson KE, et al. Among authors: canby hagino ed. J Urol. 2005 Aug;174(2):553-6; discussion 556. doi: 10.1097/01.ju.0000165184.72337.9d. J Urol. 2005. PMID: 16006890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page